';
Children's Services

RCPA, in partnership with its members, has submitted public comments in response to the Office of Mental Health and Substance Abuse Services’ (OMHSAS) proposed Licensure of Crisis Intervention Services regulations. RCPA thanks OMHSAS for their effort in creating licensing standards that align with national best practice standards for the Commonwealth’s crisis intervention system and their receptivity to further recommendations from current crisis providers.

The proposed regulations have been reviewed by members of RCPA’s 988/Crisis Work Group, who are some of the most experienced and knowledgeable leaders in Pennsylvania’s Crisis System. With their expertise, RCPA developed comments and recommendations to guide the State towards meaningful regulations for Crisis Intervention Licensure.

The largest areas of concern in the proposed regulations are in regard to the staffing requirements and fiscal impacts, which led to the following recommendations:

  • Flexibility in the staffing requirements to account for the national behavioral health workforce shortage.
  • A transparent cost analysis of the true cost of implementing the regulations to ensure that the regulations do not become an unfunded mandate.
  • Increased clarity on the role of community outpatient clinics that are not connected to larger hospital systems.
  • The assembly of a stakeholder work group, similar to the forums that OMHSAS convened for their PRTF regulations, to ensure that provider and other stakeholder concerns are addressed before promulgation of the regulations.

Read RCPA’s full public comments here. Contact Emma Sharp with any questions.

The Office of Developmental Programs (ODP) is sharing this important announcement from the PA Department of Health.

As of November 11, 2025, 15 infants with suspected or confirmed infant botulism were reported from 12 states: Arizona, California (2), Illinois (2), Kentucky, Minnesota, New Jersey, North Carolina, Oregon, Pennsylvania, Rhode Island, Texas (2), and Washington. Laboratory confirmation for some cases is ongoing. Illnesses started on dates ranging from mid-August to November 2025. All 15 infants were hospitalized and treated with BabyBIG®. No deaths were reported. Infants ranged in age from 16 to 157 days. State and local public health officials are interviewing caregivers about the foods infants were fed in the month before they got sick. All 15 (100%) reported feeding ByHeart Whole Nutrition infant formula. This investigation is ongoing, and additional cases may be identified.

All ByHeart Whole Nutrition Infant Formula products were recalled. This includes all unexpired lots of formula cans and single-serve “anywhere” sticks. The link to the recall can be found here.

According to the FDA, ByHeart Whole Nutrition Infant Formula makes up less than 1 percent of all infant formula sales in the United States. Given this small market share, recall of these products is unlikely to create shortage concerns of infant formula for parents and caregivers.

Summary:

  • On November 11, 2025, ByHeart, Inc. recalled all lots of ByHeart Whole Nutrition Infant Formula in response to the U.S. Food and Drug Administration’s (FDA’s) ongoing investigation into a recent outbreak of infant botulism.
  • According to the company’s website, ByHeart Whole Nutrition Infant Formula was sold through its website ByHeart.com and through retail stores nationwide, including Amazon, Kroger, Walmart, Whole Foods, Target, SamsClub, and others.
  • Infant botulism is a rare but potentially fatal paralytic illness that impacts babies less than one year old. Symptoms can include constipation, poor feeding, drooping eyelids, weak cry, and progressive muscle weakness.
  • Health care providers (HCP) should call the California Infant Botulism Treatment and Prevention Program (IBTPP) immediately at 510-231-7600 for consultation of suspected case. Consultation is available 24/7. Treatment with botulism immune globulin, BabyBIG®, obtained from California Department of Health, is recommended for all suspected cases of infant botulism.
  • Infant botulism is a reportable disease in PA; all suspected cases must be reported to the Pennsylvania Department of Health (DOH) at 1-877-PA-HEALTH or their local health department.

For More Information

Businessman and team work using a Laptop Computer with Webinar E-business Browsing Connection and cloud online technology webcast concept, business concept

From Chaos to Clarity: How Human Service Leaders Bring Order to Oversight
Tuesday, December 9, 2025
12:00 pm ET
Register Here

Keeping up with inspections and licensing requirements can feel like an endless chase — especially when each site or program has its own system. Many organizations are finding new ways to bring structure, visibility, and calm to these responsibilities, even with limited resources.

Join us on Tuesday, December 9, 2025, at 12:00 pm ET for From Chaos to Clarity: How Human Service Leaders Bring Order to Oversight, a live webinar co-hosted by RCPA and PUPS Software. This session brings together leaders for an open, practical conversation about streamlining inspections, licensing, and operational readiness.

Featured Panelists:

  • Jim Sharp, Chief Operating Officer & Director of Mental Health Services, RCPA
  • Savannah David, Service Director – ID/A NE Region, Step By Step, Inc.
  • Morgan Gerety, Director of Maintenance, Caring, Inc.

We’ll talk about:

  • Practical steps to bring consistency and visibility to inspections and licensing;
  • How to move from paper and spreadsheets to digital processes without overwhelming your team;
  • Real examples of accountability and readiness in action; and
  • Lessons learned from organizations that replaced annual scrambles with steady progress.

Whether your team is just getting started or already modernizing oversight, you will walk away with useful ideas, peer insights, and tools to support your next steps.

Tuesday, November 18, 2025
11:00 am ET
Register Here

Join Core Solutions in this exclusive presentation for RCPA members. This session will showcase how Cx360 Clinical Assist integrates seamlessly with your FHIR-enabled EHR to support smarter, faster clinical decisions. Get a first-hand demonstration of how Clinical Assist brings summaries, documentation, insights, planning, and other advanced capabilities directly to the point of care.

During this presentation, you will:

  • Experience AI-driven clinical insights that surface key information instantly within your workflow;
  • See real-time documentation support that reduces administrative burden and enhances accuracy; and
  • Discover how Clinical Assist empowers clinicians to make faster, more informed decisions.

Speakers will include:

  • RCPA’s COO and Mental Health Policy Director Jim Sharp, MS; and
  • Core Solution’s Director of Clinical Strategy Michael Arevalo, PsyD.